Does Candriam S.C.A. own REGN stock?

Yes. As of its Q2 2026 13F, Candriam S.C.A. holds 195,674 shares of REGN (Regeneron Pharmaceuticals), worth $121.9M.

How many shares of REGN does Candriam S.C.A. own?

As of its Q2 2026 13F, Candriam S.C.A. holds 195,674 shares of REGN (Regeneron Pharmaceuticals).

As of its Q2 2026 13F, Candriam S.C.A.'s REGN position is worth $121.9M.

In Q2 2026, Candriam S.C.A. increased its REGN position by 9,286 shares (+5.0%).

Candriam S.C.A. already held REGN in its Q1 2019 13F, the earliest on record, and has listed it in 30 quarterly 13F filings.

Position history for CSCandriam S.C.A.'s holdings in Regeneron Pharmaceuticals, Inc.

Current Value

$121.9M

Current Shares

195,674

Total Value Change

-$20.7M

Total Shares Change

-151,597

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	195,674	+5.0%	$121.9M	0.5%	$622.81	45
2026-Q1	Decreased	186,388	-9.2%	$144M	0.7%	$770.59	0
2025-Q4	Increased	205,332	+21.1%	$158.5M	0.8%	$768.90	51
2025-Q3	Increased	169,495	+19.2%	$95.3M	0.5%	$559.40	42
2025-Q2	Decreased	142,208	-33.8%	$74.7M	0.4%	$521.53	0
2025-Q1	Decreased	214,941	-17.8%	$136.3M	0.9%	$629.11	0
2024-Q4	Increased	261,498	+3.5%	$186.3M	1.1%	$705.67	50
2024-Q3	Increased	252,525	+25.8%	$265.5M	1.5%	$1,041.41	60
2024-Q2	Decreased	200,708	-7.8%	$210.9M	1.3%	$1,041.20	0
2024-Q1	Decreased	217,771	-9.9%	$209.6M	1.3%	$953.49	0
2023-Q4	Decreased	241,618	-16.8%	$212.2M	1.5%	$870.08	0
2023-Q3	Decreased	290,310	-5.0%	$238.9M	1.7%	$815.27	0
2023-Q2	Decreased	305,618	-12.4%	$219.6M	1.6%	$711.82	0
2023-Q1	Decreased	348,988	-8.9%	$263.9M	1.8%	$813.99	0
2022-Q4	Decreased	382,968	-4.9%	$276.3M	1.9%	$714.75	0
2022-Q3	Increased	402,521	+8.0%	$277.3M	2.0%	$682.43	53
2022-Q2	Increased	372,793	+0.9%	$220.4M	1.8%	$585.60	49
2022-Q1	Increased	369,290	+1.3%	$257.9M	1.8%	$691.89	49
2021-Q4	Decreased	364,586	-6.2%	$230.2M	1.5%	$625.62	0
2021-Q3	Decreased	388,643	-26.7%	$235.2M	1.6%	$599.52	0
2021-Q2	Increased	530,346	+31.4%	$296.2M	2.0%	$553.32	67
2021-Q1	Increased	403,641	0.0%	$187.3M	1.6%	$468.72	48
2020-Q4	Increased	403,637	+24.9%	$195M	1.5%	$478.59	59
2020-Q3	Increased	323,036	+41.1%	$180.8M	1.7%	$554.55	64
2020-Q2	Decreased	228,901	-44.3%	$142.8M	1.5%	$617.82	0
2020-Q1	Increased	411,216	0.0%	$150.9M	1.7%	$483.73	48
2019-Q4	Decreased	411,211	-0.2%	$154.4M	1.7%	$371.97	0
2019-Q3	Increased	412,174	+6.8%	$114.3M	1.5%	$274.81	51
2019-Q2	Increased	385,741	+11.1%	$120.2M	1.5%	$310.07	53
2019-Q1	First report	347,271	-	$142.6M	1.8%	$406.78	0

Other major holders of REGN: FMR LLC, VANGUARD GROUP INC